If successful this project will be the first example of a truly decentralized clinical trial, testing non-drug interventions for Alzheimer's disease. Furthermore, if  the result of this project yields a therapy which can remediate such diseases in any way, it will be a landmark moment for decentralized science - demonstrating that the crowd can accomplish a goal of immense public good which the traditional system has been unable to accomplish with over a trillion dollars in tax-payer funding over 30 years, and catalyzing significant changes toward decentralization within existing clinical trials infrastructure. 